Cargando…
What do the data say about chemotherapy-induced peripheral neuropathy assessment and management?
Autores principales: | Kanzawa-Lee, Grace, Knoerl, Robert |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9803917/ https://www.ncbi.nlm.nih.gov/pubmed/36593974 http://dx.doi.org/10.1016/j.apjon.2022.100170 |
Ejemplares similares
-
Characterization of Internal Validity Threats to Phase III Clinical Trials for Chemotherapy-Induced Peripheral Neuropathy Management: A Systematic Review
por: Lee, Deborah, et al.
Publicado: (2019) -
In Search of a Gold Standard Patient-Reported Outcome Measure for Use in Chemotherapy- Induced Peripheral Neuropathy Clinical Trials
por: Smith, Ellen M. Lavoie, et al.
Publicado: (2018) -
The Mediterranean Diet and Cancer: What Do Human and Molecular Studies Have to Say about It?
por: Hernáez, Álvaro, et al.
Publicado: (2019) -
What data and analytics can and do say about effective learning
por: Lodge, Jason M., et al.
Publicado: (2017) -
What do Cochrane systematic reviews say about cardiac arrest management?
por: Pacheco, Rafael Leite, et al.
Publicado: (2018)